Total body computed tomography scan in the initial work‐up of Binet stage A chronic lymphocytic leukemia patients: Results of the prospective, multicenter O‐CLL1‐GISL study
暂无分享,去创建一个
F. Angrilli | R. Foà | E. Iannitto | S. Molica | M. Federico | L. Baldini | A. Neri | S. Zupo | M. Ferrarini | G. Cutrona | C. Musolino | G. Quarta | F. Morabito | S. Matis | M. Gentile | E. Vigna | A. Recchia | F. Maura | F. Ilariucci | I. Vincelli | A. Cortelezzi | P. Musto | F. Raimondo | D. Vallisa | F. Mauro | M. Brugiatelli | S. Fabris | M. Spriano | A. Fragasso | Emanuela A Pesce | N. Renzo | P. Tonno
[1] B. Sarina,et al. Impact of B-cell count and imaging screening in cMBL: any need to revise the current guidelines? , 2012, Leukemia.
[2] S. Molica,et al. The cumulative amount of serum-free light chain is a strong prognosticator in chronic lymphocytic leukemia. , 2011, Blood.
[3] S. Molica,et al. Definition of progression risk based on combinations of cellular and molecular markers in patients with Binet stage A chronic lymphocytic leukaemia , 2009, British journal of haematology.
[4] D. Rossi,et al. The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors , 2009, British journal of haematology.
[5] Massimo Gentile,et al. Predictive value of β2-microglobulin (β2-m) levels in chronic lymphocytic leukemia since Binet A stages , 2009, Haematologica.
[6] K. Nilsson,et al. Beta 2-microglobulin in chronic lymphocytic leukaemia. , 2009, Scandinavian journal of haematology.
[7] Michael Hallek,et al. Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines. , 2008, Blood.
[8] N. Chiorazzi,et al. Clonal heterogeneity in chronic lymphocytic leukemia cells: superior response to surface IgM cross-linking in CD38, ZAP-70-positive cells , 2008, Haematologica.
[9] E. Giné,et al. Abdominal computed tomography predicts progression in patients with Rai stage 0 chronic lymphocytic leukemia. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[10] H. Kantarjian,et al. Other malignancies in chronic lymphocytic leukemia/small lymphocytic lymphoma. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[11] J. Armitage,et al. Staging Non‐Hodgkin Lymphoma , 2005, CA: a cancer journal for clinicians.
[12] T. Stankovic,et al. Mutations in the ATM gene lead to impaired overall and treatment-free survival that is independent of IGVH mutation status in patients with B-CLL. , 2005, Blood.
[13] M. Blaufox,et al. A metaanalysis of 18F‐2‐deoxy‐2‐fluoro‐D‐glucose positron emission tomography in the staging and restaging of patients with lymphoma , 2005, Cancer.
[14] K. Jain,et al. Normal organ volume assessment from abdominal CT , 2004, Abdominal Imaging.
[15] R. Reznek,et al. Computerised tomography in the staging of Hodgkin's disease and non-Hodgkin's lymphoma , 2003, European Journal of Nuclear Medicine and Molecular Imaging.
[16] B. Cheson,et al. Pre- and post-treatment evaluation of non-Hodgkin's lymphoma. , 2002, Best practice & research. Clinical haematology.
[17] H. Minn,et al. Nodal staging of lymphoma with whole-body PET: comparison of. , 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[18] J. Whittaker,et al. Deletions at 11q identify a subset of patients with typical CLL who show consistent disease progression and reduced survival , 1997, Leukemia.
[19] M. James,et al. 11q deletions identify a new subset of B-cell chronic lymphocytic leukemia characterized by extensive nodal involvement and inferior prognosis. , 1997, Blood.
[20] M. Grever,et al. National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment. , 1996, Blood.
[21] A. Polliack,et al. Pulmonary involvement as the major manifestation of chronic lymphocytic leukemia. , 1992, Leukemia & lymphoma.
[22] B. Gross,et al. Upper abdominal lymph nodes: criteria for normal size determined with CT. , 1991, Radiology.
[23] M Tubiana,et al. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[24] Mark J. Thomas,et al. A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis , 1981, Cancer.
[25] S. Malek,et al. Chronic Lymphocytic Leukemia , 2019, Methods in Molecular Biology.
[26] D C Case,et al. Clinical staging of chronic lymphocytic leukemia. , 1977, The Journal of the Maine Medical Association.